Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/a17v-t341

technical paper

ENDO 2022

July 11, 2022

Atlanta, United States

Reversal of Graves' Disease Associated Facial Volume Expansion and Eyelid Changes Following Teprotumumab Therapy

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2022

Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase 2b Study of Batoclimab in Active and Moderate-to-Severe Thyroid Eye Disease
technical paper

Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase 2b Study of Batoclimab in Active and Moderate-to-Severe Thyroid Eye Disease

ENDO 2022

George Kahaly

11 July 2022

Similar lecture

Hormone replacement promotes sexual maturation and fertility restoration in mice with congenital hypopituitarism harboring Prop1 mutation
technical paper

Hormone replacement promotes sexual maturation and fertility restoration in mice with congenital hypopituitarism harboring Prop1 mutation

ENDO 2022

Bruna Azevedo

11 July 2022

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved